Nachrichten zur Insulet Corp Aktie

Is It Time to Buy Insulet-

A big drop in this insulin-pump maker may make it the perfect time to add it to your portfolio....…

Insulets (PODD) Omnipod DASH System Now ISO 27001 Certified

Insulet (PODD) is now the only insulin pump company to be awarded with both the ISO 27001 and the DTSec…

Ypsomed steigert im Halbjahr Umsatz und Gewinn

Einmalzahlung von 50 Mio Franken aus dem ausgelaufenen Vertriebsvertrag mit Insulet....…

Insulet Achieves Quarterly Profitability for the First Time

In the third quarter, the tubeless insulin pump specialist grew revenue 24% year over year and increased full-year 2018 revenue…

Insulet (PODD) Beats Earnings and Revenue Estimates in Q3

We are encouraged by the year-over-year improvement in Insulets (PODD) Q3 results on solid uptake of Omnipod system in the…

Insulet Corporation (PODD) Q3 2018 Earnings Conference Call Transcript

PODD earnings call for the period ending September 30, 2018....…

Insulet (PODD) Q3 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insulet (PODD) Q3 Earnings and Revenues Top Estimates

Insulet (PODD) delivered earnings and revenue surprises of 50.00% and 1.74%, respectively, for the quarter ended September 2018. Do the…

Europe Okays Use of Insulets (PODD) Omnipod With Fiasp

Fiasps operative efficiency coupled with Insulets (PODD) Omnipod System will provide a new option for both patients and prescribers to…

Insulet Advances on Omnipod Reimbursement Update, Runs Risks

Insulet (PODD) commences 2018 with favorable reimbursement updates. The company attains several landmarks regarding Omnipods market reach....…

The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet

Heres a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Stocks that hit 52-week…

Zacks.com featured highlights include: Entercom, Insulet, ESCO and Tristate

Zacks.com featured highlights include: Entercom, Insulet, ESCO and Tristate...…

Insulet Achieves Operating Profitability, but Pares Back 2018 Revenue Guidance

The tubeless insulin pump specialists revenue growth slowed notably in the second quarter, but management said this is a short-term…

Insulet (PODD) Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insulet (PODD) Reports Q2 Loss, Lags Revenue Estimates

Insulet (PODD) delivered earnings and revenue surprises of 76.92% and -6.52%, respectively, for the quarter ended June 2018. Do the…

Q2 Earnings Outlook For Insulet

Dont be caught off-guard: Insulet (NASDAQ: PODD) releases its next round of earnings Thursday. Want to skip the homework and…

Insulet Omnipod Insulin Pump Finds Favor in British Columbia

Insulets (PODD) Omnipod has huge market potential in Canada as it is the only tubeless insulin pump sold in the…

Insulet Starts European Direct Operation, Braces Global Base

Insulets (PODD) goal to begin direct commercial operation in Europe is a year-long endeavor....…

Insulet übernimmt die europaweite Vermarktung für die Produktlinie Omnipod®-Insulin-Managementsystem

BILLERICA, Massachusetts, USA und LONDON, England--(BUSINESS WIRE)--Die Insulet Corporation (NASDAQ:PODD) (Insulet bzw. die Gesellschaft), führender Anbieter schlauchloser Insulinpumpen mit dem…

Ypsomed muss stärker auf eigenen Füssen stehen

Wegen der Beendigung der Zusammenarbeit mit dem US-Insulinpumpenhersteller Insulet verliert die Berner Medizintechnikfirma Ypsomed eine lukrative Einnahmequelle. Künftig will das Unternehmen…

Bernstein Litowitz Berger & Grossmann LLP and Scott + Scott Attorneys at Law LLP Announce a Proposed Settlement of the Insulet Corp. Securities Litigation

NEW YORK, May 14, 2018 /PRNewswire/ -- If you bought Insulet Corp. common stockfrom May 7,…

Insulet Delivers 21% Revenue Growth and Achieves Operating Profitability Breakeven

In the first quarter, the tubeless insulin pump specialist narrowed its earnings loss more than many investors were likely expecting....…

Insulet (PODD) Q1 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Insulet Reports Q1 Loss Per Share $0.11

* INSULET REPORTS FIRST QUARTER 2018 REVENUE OF $123.6 MILLION, UP 21% YEAR-OVER-YEAR, AND GROSS MARGIN OF 61.4%, UP 300 BASIS POINTS, EXCEEDING…

Stock Review for Medical Supplies Investors -- Insulet, Integra LifeSciences, Mazor Robotics, and Microbot Medical

NEW YORK, May 02, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the…

BRIEF-Insulet Establishes Two Significant Commercial Partnerships To Support Its European Expansion

* INSULET ESTABLISHES TWO SIGNIFICANT COMMERCIAL PARTNERSHIPS TO SUPPORT ITS EUROPEAN EXPANSION...…

Insulet baut zwei wichtige Handelspartnerschaften auf und expandiert damit auf dem europäischen Markt

BILLERICA, Mass. und London, UK--(BUSINESS WIRE)--Die Insulet Corporation (NASDAQ:PODD) (Insulet bzw. die Gesellschaft), das führende Unternehmen für schlauchlose Insulinpumpen und…

Pre-Market Technical Scan on Medical Supplies Equities -- Insulet, Integra LifeSciences, Mazor Robotics, and Microbot Medical

NEW YORK, March 23, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the…

Insulet Corporation: A New Golden Age For The Company And The Treatment Of Diabetes

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Analyst: Insulet On Track For Profitability In 2018

Insulet Corporation (NASDAQ: PODD) is up 80.5 percent year-over-year, and even last quarters bottom-line miss cant deter the biotechs bulls. …

Insulet Pumps Out 26% Revenue Growth; Loss Narrows

The tubeless insulin pump specialist capped off a strong 2017 with a solid fourth quarter....…

Insulet Corporations (PODD) CEO Patrick Sullivan on Q4 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insulet Q4 Earnings Preview

Insulet (NASDAQ: PODD) releases its next round of earnings Wednesday. Get the latest predictions in Benzingas essential guide to the…

Whats Happening With These Medical Supplies Stocks- -- Tandem Diabetes Care, Integra LifeSciences, OraSure Technologies, and Insulet

NEW YORK, Feb. 1, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. …

Ascensia Diabetes Care Expands Strategic Alliance with Insulet Corporation by Signing Commercial Agreement

BASEL, Switzerland, January 9, 2018 /PRNewswire/ -- Ascensia Diabetes Care today announced it has expanded the scope…

BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp

* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT...…

Heres Why Insulet Corporation Jumped Today

Shares soar after management announced a big reimbursement win....…

4 Tailwinds Driving Raymond James Insulet Bull Case

Raymond James identified four major tailwinds for Insulet Corporation (NASDAQ: PODD) that the firm said could help drive…

United States $6 Billion Insulin Delivery Devices Market Outlook to 2022 - Major Players are Insulet, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi & Owen Mumford

DUBLIN, November 21, 2017 /PRNewswire/ -- The "United States Insulin Delivery Devices Market Outlook 2017: Key Product…

Medical Supplies Stocks on Investors Radar -- Insulet, Glaukos, West Pharmaceutical Services, and TransEnterix

NEW YORK, November 15, 2017 /PRNewswire/ -- If you want a Stock Review on PODD, GKOS, WST,…

BRIEF-Insulet announces pricing of convertible senior notes due 2024

* Insulet announces pricing of convertible senior notes due 2024...…

Closing Bell Ringer: November 6, 2017

Ringing today's closing bells are Radian Group with CEO Rick Thornberry celebrating their 25th anniversary of listing and 40th anniversary…

Heres Why Insulet Corporations Investors Are Pumped

Shares leap after the company reports expectation-smashing results....…

Insulet Posts 28% Revenue Growth and Raises 2017 Outlook on Soaring International Sales

The drug delivery specialists key metrics continued to move in the right direction in the third quarter....…

Insulet (PODD) Q3 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lifshitz & Miller LLP Announces Investigation of AcelRx Pharmaceuticals, Inc., Bob Evans Farms, Inc., Calgon Carbon Corporation, Exa Corporation, Insulet Corporation, K12 Inc., PG&E Corporation

NEW YORK, Oct. 24, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX) Lifshitz & Miller…

Insulet Corporation präsentiert Daten aus der klinischen Praxis zur Anwendung ihres Omnipod®-Insulinmanagementsystems bei ca. 39.000 Patienten unter Verwendung eines Cloud-basierten Datenverwaltungssystems

BILLERICA, Mass.--(BUSINESS WIRE)--Die Insulet Corporation (NASDAQ:PODD) (Insulet oder das Unternehmen), der führende Anbieter schlauchloser Insulinpumpen-Technologie, hat heute auf dem Kongress…